The Business Research Company
The Business Research Company’s Oncology Molecular Diagnostics Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, August 20, 2026 /EINPresswire.com/ — “The field of oncology molecular diagnostics is witnessing significant momentum as advancements in technology and personalized medicine reshape cancer diagnosis and treatment. With increasing cancer prevalence and innovations in molecular testing, this sector is poised for strong growth in the coming years. Let’s explore the market size, key drivers, regional insights, and emerging trends shaping the future of oncology molecular diagnostics.
Market Size and Growth Trajectory of Oncology Molecular Diagnostics
The oncology molecular diagnostics market has experienced rapid expansion in recent years. It is projected to rise from $5.65 billion in 2025 to $6.34 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.2%. This past growth has been fueled by factors such as the rising incidence of cancer, wider adoption of PCR and sequencing technologies, increased funding for oncology research, expansion of diagnostic services in hospitals, and regulatory approvals for molecular diagnostic tests.
Download a free sample of the oncology molecular diagnostics market report:
Looking ahead, the market is expected to accelerate its growth, reaching $10.13 billion by 2030 with an anticipated CAGR of 12.4%. Drivers for this surge include the growing use of precision oncology, advancements in liquid biopsy technologies, heightened demand for personalized cancer treatments, the integration of AI for data interpretation, and expanding penetration into emerging markets. Key trends during this forecast period are expected to include the rise of companion diagnostics, broader application of liquid biopsy, growth in biomarker-based testing, expanding cancer screening initiatives, and an increasing focus on early and accurate cancer detection.
Understanding Oncology Molecular Diagnostics and Its Scope
Oncology molecular diagnostics involves techniques and services used to diagnose cancer by analyzing genetic markers, proteins, or other molecular components that provide critical health and disease information. These diagnostic tests play a crucial role in identifying specific cancer types and guiding targeted therapies, thereby improving treatment precision and patient outcomes.
View the full oncology molecular diagnostics market report:
Personalized Medicine as a Primary Growth Catalyst in Oncology Molecular Diagnostics
One of the most influential factors driving the oncology molecular diagnostics market is the growing demand for personalized medicine. This approach customizes medical treatments and healthcare strategies to the individual patient, ensuring more effective and tailored interventions. Molecular diagnostics are vital in this context, as they enable the development of individualized treatment plans, precise drug selection, and enhanced therapeutic effectiveness, ultimately boosting patient quality of life.
For example, in February 2024, the Personalized Medicine Coalition, a nonprofit organization based in the United States, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, a significant increase from six approvals in 2022. Such developments highlight the rising emphasis on personalized medicine, which in turn propels demand within the oncology molecular diagnostics arena.
Regional Overview of the Oncology Molecular Diagnostics Market
In 2025, North America held the largest share of the global oncology molecular diagnostics market, maintaining its leadership position globally. Western Europe followed as the second largest region in terms of market size. The comprehensive market analysis also covers other key regions including Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East, and Africa, providing a wide-ranging perspective on global market dynamics and regional growth opportunities.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: [email protected]
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company”
Oliver Guirdham
The Business Research Company
+44 7882 955267
[email protected]
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Article originally published on www.einpresswire.com as Oncology Molecular Diagnostics Market Trends Support A 12.4% CAGR Outlook Through The Forecast Period
